A double-blind, randomized, placebo-controlled study with JNJ-37822681, a novel, highly selective, fast dissociating D2 receptor antagonist in the treatment of acute exacerbation of schizophrenia
Titel:
A double-blind, randomized, placebo-controlled study with JNJ-37822681, a novel, highly selective, fast dissociating D2 receptor antagonist in the treatment of acute exacerbation of schizophrenia
Auteur:
Schmidt, Mark E. Kent, Justine M. Daly, Ella Janssens, Luc Van Osselaer, Nancy Hüsken, Gitta Anghelescu, Ion-George Van Nueten, Luc